Table 2.
Capacity issues and COVID testing during the pandemic
| Number of respondents in each category (percentages in brackets) |
|||
|---|---|---|---|
| COVID-low n = 65 | COVID-high n = 80 | OVERALL n = 145 | |
| Percentage of normal OR activity | |||
| 0–25% | 11 (16.9) | 27 (33.8) | 38 (26.2) |
| 26–50% | 20 (30.8) | 33 (41.3) | 53 (36.6) |
| 51–75% | 8 (12.3) | 12 (15) | 20 (13.8) |
| 76–100% | 20 (30.8) | 5 (6.3) | 25 (17.2) |
| Increase in ICU capacity | |||
| None | 20 (30.8) | 5 (6.25) | 25 (17.2) |
| <50% | 19 (29.2) | 18 (22.5) | 37 (25.5) |
| 50–100% | 12 (18.5) | 22 (27.5) | 34 (23.4) |
| >100% | 14 (21.5) | 35 (43.75) | 49 (33.8) |
| ICU capacity filled with COVID + ve patients | |||
| <24% | 38 (58,5) | 13 (16.3) | 51 (35.2) |
| 25–49% | 5 (7.7) | 14 (17.5) | 19 (13.1) |
| 50–74% | 8 (12.3) | 17 (21.3) | 25 (17.2) |
| >75% | 14 (21.5) | 36 (45) | 50 (34.5) |
| Non-essential surgical procedures | |||
| Stopped | 53 (81.5) | 67 (83.8) | 120 (82.8) |
| Occasional | 8 (12.3) | 11 (13.8) | 19 (13.1) |
| Ongoing | 4 (6.2) | 2 (2.5) | 6 (4.1) |
| Pre-operative COVID testing | |||
| No | 31 (48.4) | 21 (26.6) | 52 (36.4) |
| Nasal swabs | 15 (23.4) | 29 (36.7) | 44 (30.8) |
| CT | 4 (6.3) | 2 (2.5) | 6 (4.2) |
| Nasal swabs + CT | 11 (17.2) | 21 (26.6) | 32 (22.4) |
| Nasal swabs, antibodies + CT | 3 (4.7) | 1 (1.3) | 4 (2.8) |